+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transfusion Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851314
  • Report
  • February 2019
  • Region: Global
  • 170 pages
  • Transparency Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

Transfusion Technology Market - Overview 

This report studies the current as well as future prospects of the global transfusion technology market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of transfusion technology and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study. The section also provides information and data analysis of the global transfusion technology market in terms of product, end-user, and region. 

The global transfusion technology market has been segmented based on product, end-user, and region. In terms of product, the global market has been classified into instruments and disposables & consumables. The instruments segment has been further bifurcated into apheresis system & multicomponent collection systems, cell processing systems & cell expansion systems, auto transfusion devices, and others. The others segment includes tube sealing system, sterile tubing welder, mixer technology, and point of care hemoglobin meters. Based on end-user, the global transfusion technology market has been segregated into hospitals, blood banks, biotechnology & pharmaceutical companies, and others. The blood banks segment is expected to dominate the global transfusion technology market during the forecast period. 

Top-down approach has been employed for determining the size of the global transfusion technology market, using various market indicators obtained from secondary sources, which included analysis of launched products and mapping of demand for transfusion technology of top market players in specific regions. Top-down approach has been used to derive the market size of different product segments, wherein market size of parent market was obtained through secondary sources and analyzed for sales by narrowing down to revenue percentage for product segment through extensive analysis of investor presentations, press releases, primary interviews, and others. Data triangulation is based on both secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. Market value and forecast, in terms of US$ Mn, for each segment has been provided for the period from 2016 to 2026. The report also provides compound annual growth rate (CAGR) in percentage for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year. 

The overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have significant impact on the global transfusion technology market and may influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition in the market across regions. These analyses are likely to help market players take strategic decisions to strengthen their positions and grow their share in the global transfusion technology market. The report also comprises technological advancement overview. 

In terms of region, the global transfusion technology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries in the above mentioned regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and growth opportunities has been provided in the overview section. 

Major players operating in the global transfusion technology market are Haemonetics Corporation, Inc., Medtronic plc, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi AG (Fresenius SE & Co. KGaA), GE Healthcare, Miltenyi Biotec, TERUMO BCT, and LivaNova PLC.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Transfusion Technology

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transfusion Technology Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Technological Advancement in Apheresis System & Multi-Component Separator Systems
5.2. Key Trends of Transfusion Technology

6. Global Transfusion Technology Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Transfusion Technology Market Value Forecast, by Product, 2016-2026
6.3.1. Instruments
6.3.1.1. Apheresis System & Multicomponent Collection Systems
6.3.1.2. Cell Processing Systems & Cell Expansion Systems
6.3.1.3. Auto Transfusion Devices
6.3.1.4. Others
6.3.2. Disposables & Consumables
6.4. Global Transfusion Technology Market Attractiveness, by Product

7. Global Transfusion Technology Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Transfusion Technology Market Value Forecast, by End-user, 2016-2026
7.3.1. Hospitals
7.3.2. Blood Banks
7.3.3. Biotechnology & Pharmaceutical Companies
7.3.4. Others
7.4. Global Transfusion Technology Market Attractiveness, by End-user

8. Global Transfusion Technology Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Transfusion Technology Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Transfusion Technology Market Attractiveness, by Region

9. North America Transfusion Technology Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Transfusion Technology Market Value Forecast, by Product, 2016-2026
9.2.1. Instruments
9.2.1.1. Apheresis System & Multicomponent Collection Systems
9.2.1.2. Cell Processing Systems & Cell Expansion Systems
9.2.1.3. Auto Transfusion Devices
9.2.1.4. Others
9.2.2. Disposables & Consumables
9.3. North America Transfusion Technology Market Value Forecast, by End-user, 2016-2026
9.3.1. Hospitals
9.3.2. Blood Banks
9.3.3. Biotechnology & Pharmaceutical Companies
9.3.4. Others
9.4. North America Transfusion Technology Market Value Forecast, by Country, 2016-2026
9.4.1. U.S.
9.4.2. Canada
9.5. North America Transfusion Technology Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country

10. Europe Transfusion Technology Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Transfusion Technology Market Value Forecast, by Product, 2016-2026
10.2.1. Instruments
10.2.1.1. Apheresis System & Multicomponent Collection Systems
10.2.1.2. Cell Processing Systems & Cell Expansion Systems
10.2.1.3. Auto Transfusion Devices
10.2.1.4. Others
10.2.2. Disposables & Consumables
10.3. Europe Transfusion Technology Market Value Forecast, by End-user, 2016-2026
10.3.1. Hospitals
10.3.2. Blood Banks
10.3.3. Biotechnology & Pharmaceutical Companies
10.3.4. Others
10.4. Europe Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016-2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Transfusion Technology Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region

11. Asia Pacific Transfusion Technology Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Transfusion Technology Market Value Forecast, by Product, 2016-2026
11.2.1. Instruments
11.2.1.1. Apheresis System & Multicomponent Collection Systems
11.2.1.2. Cell Processing Systems & Cell Expansion Systems
11.2.1.3. Auto Transfusion Devices
11.2.1.4. Others
11.2.2. Disposables & Consumables
11.3. Asia Pacific Transfusion Technology Market Value Forecast, by End-user, 2016-2026
11.3.1. Hospitals
11.3.2. Blood Banks
11.3.3. Biotechnology & Pharmaceutical Companies
11.3.4. Others
11.4. Asia Pacific Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016-2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Transfusion Technology Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region

12. Latin America Transfusion Technology Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Transfusion Technology Market Value Forecast, by Product, 2016-2026
12.2.1. Instruments
12.2.1.1. Apheresis System & Multicomponent Collection Systems
12.2.1.2. Cell Processing Systems & Cell Expansion Systems
12.2.1.3. Auto Transfusion Devices
12.2.1.4. Others
12.2.2. Disposables & Consumables
12.3. Latin America Transfusion Technology Market Value Forecast, by End-user, 2016-2026
12.3.1. Hospitals
12.3.2. Blood Banks
12.3.3. Biotechnology & Pharmaceutical Companies
12.3.4. Others
12.4. Latin America Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016-2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Transfusion Technology Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region

13. Middle East & Africa Transfusion Technology Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Transfusion Technology Market Value Forecast, by Product, 2016-2026
13.2.1. Instruments
13.2.1.1. Apheresis System & Multicomponent Collection Systems
13.2.1.2. Cell Processing Systems & Cell Expansion Systems
13.2.1.3. Auto Transfusion Devices
13.2.1.4. Others
13.2.2. Disposables & Consumables
13.3. Middle East & Africa Transfusion Technology Market Value Forecast, by End-user, 2016-2026
13.3.1. Hospitals
13.3.2. Blood Banks
13.3.3. Biotechnology & Pharmaceutical Companies
13.3.4. Others
13.4. Middle East & Africa Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016-2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Transfusion Technology Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles
14.2.1. General Electric Healthcare
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Strategic Overview
14.2.1.5. Financial Overview
14.2.2. Haemonetics Corporation
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.2.3. SWOT Analysis
14.2.2.4. Strategic Overview
14.2.2.5. Financial Overview
14.2.3. TERUMO BCT
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Product Portfolio
14.2.3.3. SWOT Analysis
14.2.3.4. Strategic Overview
14.2.3.5. Financial Overview
14.2.4. B. Braun Melsungen AG
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Product Portfolio
14.2.4.3. SWOT Analysis
14.2.4.4. Strategic Overview
14.2.4.5. Financial Overview
14.2.5. Fresenius Kabi AG
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Product Portfolio
14.2.5.3. SWOT Analysis
14.2.5.4. Strategic Overview
14.2.5.5. Financial Overview
14.2.6. Medtronic
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Product Portfolio
14.2.6.3. SWOT Analysis
14.2.6.4. Strategic Overview
14.2.6.5. Financial Overview
14.2.7. LivaNova PLC
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Product Portfolio
14.2.7.3. SWOT Analysis
14.2.7.4. Strategic Overview
14.2.7.5. Financial Overview
14.2.8. Kawasumi Laboratories Inc.
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Product Portfolio
14.2.8.3. SWOT Analysis
14.2.8.4. Strategic Overview
14.2.8.5. Financial Overview
14.2.9. Lmb Technologie GmbH
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Product Portfolio
14.2.9.3. SWOT Analysis
14.2.9.4. Strategic Overview
14.2.9.5. Financial Overview
14.2.10. Miltenyi Biotec
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Product Portfolio
14.2.10.3. SWOT Analysis
14.2.10.4. Strategic Overview
14.2.10.5. Financial Overview
14.2.11. Asahi Kasei Medical Co., Ltd.
14.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.11.2. Product Portfolio
14.2.11.3. SWOT Analysis
14.2.11.4. Strategic Overview
14.2.11.5. Financial Overview
14.2.12. Cerus Corporation
14.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.12.2. Product Portfolio
14.2.12.3. SWOT Analysis
14.2.12.4. Strategic Overview
14.2.12.5. Financial Overview
Note: Product cover images may vary from those shown
Adroll
adroll